IQST nine-month revenue up 34.5% but thin margins and dilution cast doubt on headline growth
Read source articleWhat happened
iQSTEL reported $313.0M in nine-month revenue, up 34.5% year over year, with its telecom segment generating $1.31M in operating income and stockholders' equity reaching $17.67M. This top-line growth must be viewed alongside the company's persistent low gross margin (2.1% in Q1'26) and the operating loss of $0.96M reported in the most recent 10-Q, which suggests the nine-month period is unlikely to be profitable on a consolidated basis. The $17.67M equity figure is a sharp increase from the $10.1M reported at Q1'26, pointing to heavy use of the M2B equity purchase facility, which sells shares at a 6% discount to the lowest VWAP and directly transfers value from existing holders. Notably, the press release omits any update on the ULTRANET acquisition, which was the key catalyst for the bull case and was targeted for a definitive agreement by early August 2026. Until IQST demonstrates positive operating cash flow and provides a clear ULTRANET timeline, the revenue growth should be treated as a low-quality acceleration that does not justify a re-rating.
Implication
The 34.5% revenue increase is largely volume-driven with gross margin around 2%, meaning that incremental revenue contributes almost nothing to covering fixed costs and interest expense. The telecom segment's $1.31M operating income for nine months is not the same as consolidated net income; Q1'26 alone showed a net loss of $1.39M, and fintech losses plus corporate overhead likely keep the full-year result negative. The jump in stockholders' equity to $17.67M strongly suggests continued draws on the $50M M2B equity line, which sells shares at 94% of the lowest daily VWAP and structurally dilutes existing shareholders. The absence of any ULTRANET update in this release after the previous 60-day target for a definitive agreement has passed signals that the acquisition is stalled or repriced, removing a key near-term catalyst. Investors should wait for the Q3 10-Q to confirm whether operating cash flow turned positive and whether going-concern language was removed; until then, the risk of further value leakage from dilution outweighs the revenue growth story.
Thesis delta
The original WAIT thesis depended on a ULTRANET definitive agreement by early August 2026 and a subsequent positive cash flow inflection; this release provides no ULTRANET update, suggesting the catalyst has slipped. The increase in stockholders' equity is consistent with continued equity-line draws, reinforcing the bear path of dilution without fundamental profit accretion. As a result, the thesis shifts from a cautious wait-and-see to a more defensive stance: avoid adding until proof of profitability and deal closure appears in SEC filings.
Confidence
High